Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.4M Buy
108,238
+1,556
+1% +$332K 0.04% 340
2026
Q1
$21.3M Buy
106,682
+8,018
+8% +$1.73M 0.04% 382
2025
Q4
$22.6M Buy
98,664
+5,917
+6% +$1.23M 0.04% 361
2025
Q3
$14.9M Buy
92,747
+1,556
+2% +$246K 0.03% 448
2025
Q2
$15.4M Buy
+91,191
New +$14.2M 0.03% 426

Other funds holding NTRA

Aviva's NTRA Position: Q2 2026 in Review

Aviva increased its Natera (NTRA) stake by 1.5% in Q2 2026, buying an estimated $332K and bringing the position to 108,238 shares worth $29.4M. The position accounts for 0.04% of the portfolio, ranked #340.

Aviva first reported a position in NTRA in Q2 2025 and has held it in 5 quarters since. 846 funds tracked by Wall St. Rank hold NTRA as of Q2 2026.

  • Aviva held 108,238 shares of Natera worth $29.4M as of Q2 2026.
  • Aviva bought 1,556 Natera shares in Q2 2026, an estimated $332K.
  • Natera made up 0.04% of Aviva's portfolio in Q2 2026, its #340 holding.
  • Aviva first reported a position in Natera in Q2 2025 and has held it in 5 quarters since.
  • 846 funds tracked by Wall St. Rank held Natera as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.